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Abstract 
Iron metabolism and erythropoiesis are inherently interlinked physiological 
processes. Regulation of iron metabolism is mediated by the iron-regulatory 
hormone hepcidin. Hepcidin limits the amount of iron released into the blood by 
binding to and causing the internalization of the iron exporter, ferroportin. A number 
of molecules and physiological stimuli, including erythropoiesis, are known to 
regulate hepcidin. An increase in erythropoietic demand decreases hepcidin, 
resulting in increased bioavailable iron in the blood. Transferrin receptor 2 (TFR2) is 
involved in the systemic regulation of iron metabolism. Patients and mice with 
mutations in TFR2 develop hemochromatosis due to inappropriate hepcidin levels 
relative to body iron.  
Recent studies from our laboratory and others have suggested an additional role for 
TFR2 in response to iron-restricted erythropoiesis. These studies used mouse 
models with perturbed systemic iron metabolism: anemic mice lacking matriptase-2 
and Tfr2, or bone marrow transplants from iron-loaded Tfr2 null mice were used.  We 
developed a novel transgenic mouse model which lacks Tfr2 in the hematopoietic 
compartment, enabling the delineation of the role of Tfr2 in erythroid development 
without interfering with its role in systemic iron metabolism. We show that in the 
absence of hematopoietic Tfr2 immature polychromatic erythroblasts accumulate 
with a concordant reduction in the percentage of mature erythroid cells in the spleen 
and bone marrow of anemic mice. These results demonstrate that erythroid Tfr2 is 
essential for an appropriate erythropoietic response in iron-deficient anemia.  These 
findings may be of relevance in clinical situations in which an immediate and efficient 
erythropoietic response is required. 
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Introduction 
In order to maintain a steady supply of erythrocytes, most of the iron absorbed in the 
body is utilized in the production of hemoglobin. The recycling of iron from senescent 
erythrocytes is also a major contributor to the body iron needs [1], thus creating an 
important bridge between iron metabolism and erythropoiesis. 
Erythropoiesis itself is a known negative regulator of the iron regulatory hormone 
hepcidin (Hamp) [2, 3]. Although the exact molecular details of this regulation are not 
well understood, it is believed that the erythroid compartment releases a soluble 
factor which limits the production of Hamp in the liver [4].  Several candidate 
regulators including growth differentiation factor 15 (GDF15), twisted gastrulation 1 
(TWSG1) and more recently erythroferrone (ERFE) have been reported [4-6].  
Stress such as iron deficiency stimulates the erythroid compartment in the bone 
marrow (BM) and this usually spills over to extramedullary sites such as the spleen 
and liver. An efficient erythropoietic response in conditions such as iron-deficiency 
anemia is essential for a proper recovery from conditions which impair oxygen 
delivery to the tissues, including cardiac and pulmonary syndromes, chronic anemic 
conditions (resulting from dietary iron deficiency or chronic disease), blood loss and 
therapeutic procedures such as chemotherapy and transplantation [7], whereas an 
inappropriate activation of this pathway has been associated with predisposition to 
leukemic transformation [8]. 
Transferrin receptor 2 (TFR2) is involved in the regulation of iron metabolism; 
patients and mice harboring TFR2 mutations develop type III hereditary 
hemochromatosis, characterized by inappropriate hepcidin expression relative to 
body iron levels [9-12]. Analysis of mice with a hepatocyte-specific deletion of Tfr2 
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demonstrated the importance of hepatic TFR2 in iron metabolism [13], as they 
develop similar iron overload as the Tfr2 total knockout mice. 
In addition to the liver, Tfr2 expression was also detected in the bone marrow and 
early erythroid progenitors [14] with expression decreasing with cell differentiation 
[14]. Real-time PCR analysis revealed that Tfr2 expression begins between day 8 
and 11 of embryonic development, which coincides with the time when primary 
hematopoietic cells move from the yolk sac to the liver for initial hematopoiesis [15]. 
These observations are suggestive of a relation between TFR2 and erythropoiesis. 
This concept is also supported by recent genome wide association studies (GWAS) 
which found an association between TFR2 and various hematological parameters 
[16-19]. In one GWAS, an association was found between red blood cell (RBC) 
number and a SNP centered on the TFR2 gene [16], although the authors did 
mention that another candidate for this association could be erythropoietin (EPO) 
[16, 18]. There was also a strong correlation between the hemoglobin content, 
hematocrit, mean cell volume and the TFR2-EPO locus in another study [17]. More 
recently a low frequency 5’ donor splice variant of TFR2 was independently 
associated with higher hematocrit levels and hemoglobin concentration [19]. 
It has been suggested that TFR2 can form a complex with EPOR in the UT7 cell line 
(endogenous protein) and transfected HEK293 cells [20]. The complex could be 
detected even after treatment with Brefeldin A, suggesting that the complex is 
formed in the early stages, probably in the endoplasmic reticulum [20]. The 
expression of TFR2 in HEK293 cells appeared to increase the surface localization of 
the erythropoietin receptor (EPOR), indicating that TFR2 could be involved in 
trafficking of the EPOR. Erythroid progenitors from 4-week-old TfR2-/- mice had 
reduced colony-forming ability in the presence of physiological concentrations of 
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EPO, suggesting that TFR2 is required for the differentiation of erythroid progenitors 
[20]. The results of these experiments suggested that TFR2 is required for the proper 
differentiation of erythroid cells. 
Recent studies using transgenic mice lacking Tmprss6 and Hfe or Tfr2 [21, 22] or 
Tmprss6, Hfe and Tfr2 [23] have suggested a role for Tfr2 in iron-restricted anemia. 
Although the results from these studies suggested an erythroid function for Tfr2, this 
function could not be directly attributed to hematopoietic Tfr2 expression, as all the 
studies used total Tfr2 knockout (KO) mice.  Using bone marrow transplant 
experiments to limit Tfr2 in the hematopoietic compartment of wild-type mice, it has 
been recently suggested that Tfr2 is required for the regulation of red blood cell 
production [24]. 
We hypothesized that TFR2 expression in the erythroid compartment is essential for 
erythropoiesis in iron-deficiency induced anemia. In order to test this, we generated 
mice lacking Tfr2 in the erythroid compartment by crossing Vav-Cre+/- mice with 
Tfr2∆/f mice. Erythropoiesis in iron-deficient anemic conditions was induced by 
feeding mice an iron-deficient diet from birth which induced anemia. In doing so, we 
have generated a novel model to delineate the role of Tfr2 in erythropoiesis without 
affecting its iron-regulatory functions. We show that loss of hematopoietic Tfr2 
results in an increase in immature erythroid cells and a decrease in the percentage 
of mature erythroid cells in anemic mice. This novel model provides definitive 
evidence for the role of Tfr2 in terminal erythroid differentiation under anemic 
conditions.  
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Materials and methods 
Generation of Tfr2 ∆/f/Vav-Cre+/- mice 
Animal experimentation was performed as per the guidelines and approval of the 
QIMR Berghofer (QIMRB) Animal Ethics Committee. Animals, housed under a 12 
hour light/dark cycle, were provided food and water ad libitum. Tfr2f/f female mice 
were bred with Tfr2+/+/Vav-Cre+/- mice. Tfr2∆/+/Vav-Cre+/- male mice were then bred 
with Tfr2f/f female mice to generate Tfr2 ∆/f/Vav-Cre-/- (control) and Tfr2 ∆/f Vav-Cre+/- 
(KO) mice. Mice with a heterozygous floxed allele were used to avoid germ-line 
transmission of the Vav-Cre allele [25]. Only mice generated from Cre+/- male mice 
were used; the progeny of the females with the Cre allele were discarded  as 
suggested [25, 26]. Control and knockout mice were fed a control (iron content: 68 
mg/Kg) or an iron-deficient (ID) (iron content: 2-10 mg/Kg) diet (Specialty Feeds, 
Glen Forest, Western Australia) from birth. All mice were on a C57BL/6J 
background. 
 
Hematological parameters, tissue and serum iron indices 
Whole blood analysis, serum iron indices, splenic (SIC) and hepatic (HIC) iron 
concentrations were measured as described [23, 27].  
 
Histology 
Formalin (10%) fixed tissues were processed, paraffin embedded, sectioned and 
H&E staining was performed at the QIMRB Histotechnology Facility. Perls’ staining 
was performed as described [28]. Slides were scanned and analyzed using the 
Aperio Scanscope XT and software (Aperio, Vista, CA) (Aperio). 
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Real time PCR 
Total RNA from BM, kidney, liver or spleen was used to prepare cDNA 
(SensiFASTTM kit, Bioline, Sydney, NSW, Australia). Real-time quantitative-PCR 
(qPCR) was performed using SensiFASTTM SYBR No-Rox (Bioline) and the following 
conditions: 5 minutes denature at 95°C, 45 cycles of 95°C for 15 seconds, 60°C for 
10 seconds and 72°C degrees for 15 seconds. The expression of all target genes 
was normalized to the geometric mean of three reference genes: β-actin (Actb), 
hypoxanthine-guanine phosphoribosyl transferase (Hprt) and DNA-directed RNA 
polymerase II subunit RPB1 (Polr2a). Primer pairs are listed in Supplementary table 
1. 
 
Flow cytometric analyses and cell sorting 
BM cells and splenocytes were isolated by passing through a 40 µm cell strainer into 
10 ml phosphate buffered-saline (PBS) with 2% fetal calf serum (FCS). The cells 
were then stained with Ter119-fluoroscein-isothiocyanate (FITC) (1:100) (Milteyni 
Biotec, Bergisch Gladbach, Germany), CD44–allophycocyanin (APC) (1:100) 
(Biolegend, San Diego, CA) and EPOR–phycoerytherin (PE) (1:100) (Sino Biological 
Inc, Beijing, China) for 1 hour. The stained single cell suspensions were either 
analyzed using the LSR Fortessa 4 cytometer (BD Biosciences, Franklin Lakes, NJ) 
or sorted into five different populations as described previously[29]. The data plots 
and graphs were generated using the FlowJo software package (Tree Star Inc., 
Ashland, OR). The sorted cells were centrifuged at 10,000 rpm for 5 minutes and re-
suspended in TRIzol for RNA extraction. 
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Statistical Analyses 
Statistical analysis on the variables between different groups of mice was performed 
by using two-way analysis of variance (ANOVA). Post-hoc analysis was performed to 
compare the differences between individual groups using Tukey’s multiple 
comparison tests. P-values <0.05 were considered to be statistically significant. 
Statistical analysis was performed using the GRAPHPAD PRISM 6 software 
(GraphPad Software, San Diego, CA). 
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Results 
Tfr2∆/f/Vav-Cre+/- animals have reduced Tfr2 expression in the bone marrow 
The control animals used for this study were heterozygous for the deleted and floxed 
Tfr2 alleles.This was done to avoid potential issues due to germ-line transmission of 
the Vav-Cre+/- allele, as previously reported [25]. Previous studies have shown that 
haplo-insufficiency of TFR2 does not alter systemic iron metabolism and a single 
allele in the heterozygous animals is sufficient to maintain appropriate iron levels [11, 
12]. It has been suggested that the Vav-Cre allele could be expressed in the ovaries, 
hence increasing the chance of germ-line transmission through the females [25, 26]. 
In view of this, only mice generated from a breeding between a Cre+/- male were 
used for the analyses performed in this study.  
Quantitative real-time PCR (qRT-PCR) shows that the KO mice have virtually no 
expression of Tfr2 mRNA in the BM (Figure 1A) as compared to the control mice. 
There were no differences in the Tfr2 levels in the spleens of the control and KO 
mice (Figure 1B). The mice fed an ID diet had less Tfr2 in the spleens (Figure 1B) as 
compared to the mice on a control diet but this was not significant. Interestingly, the 
livers of the KO mice had significantly lower Tfr2 levels as compared to the control 
mice (Figure 1C). Potentially this reduced hepatic Tfr2 expression could result in 
increased iron levels in the KO mice which could affect erythropoiesis and hence the 
interpretations of the study. Thus, we first examined the effects on iron indices in 
these mice. 
Loss of hematopoietic Tfr2 does not affect systemic iron homeostasis  
In order to determine whether the loss of hematopoietic Tfr2 and a reduction of 
hepatic Tfr2 in the KO mice alters systemic iron metabolism, we measured HIC and 
SIC, as well as total serum iron and transferrin saturation. Figure 1D shows that 
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there were no significant differences in the HIC, SIC, serum iron and transferrin 
saturation of the KO and control mice on similar diets.  As expected the iron indices 
(HIC, SIC, total serum iron and transferrin saturation) for the mice fed an ID diet 
were significantly lower as compared to the mice fed a control diet. 
In addition, we determined the localization of iron in the livers of KO and control 
animals by Perls’ staining. As seen in supplementary figure 1A, no visible differences 
in iron deposition in the livers of the KO and control mice was observed. These 
results indicated appropriate systemic iron regulation in mice even with a 
heterozygous deletion of Tfr2, as described previously [11, 12].  
The liver sections of the KO mice fed an ID diet looked significantly different from the 
control mice. There was a significant increase in the number of nucleated erythroid 
cells (shown by black arrows in the right most panel in Supplementary figure 1A). 
This was indicative of increased erythropoiesis in the liver.  
The relative mRNA expression of genes involved in regulating iron homeostasis was 
also measured in the livers of control and KO mice. The expression levels of bone 
morphogenetic protein 6 (Bmp6) (Supplementary figure 2A) and ferroportin (Fpn1) 
(Supplementary figure 2C) were similar in the control and KO mice, while the KO 
mice had slightly lower basal levels of hepatic Hamp as compared to the control 
mice, but this difference was not significant (Supplementary figure 2B); and as seen 
in Figure 1D and Supplementary figure 2A it does not affect the overall systemic 
regulation of iron homeostasis. 
KO mice fed an ID diet show splenomegaly and extramedullary hematopoiesis in the 
spleen and the liver.  
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The control and KO mice fed an ID diet had significantly enlarged spleens as 
compared to the animals fed a control diet (Supplementary figure 3A). Moreover, the 
KO mice fed an ID diet had larger spleens as compared to their control counterpart 
littermates (Supplementary figure 3A). Splenomegaly is indicative of extramedullary 
hematopoiesis (EMH). 
Various hematological parameters were also measured using whole blood from 
these mice (Supplementary figure 3B, C and D). Although there were no significant 
differences based on the genotype of the mice, the KO mice had slightly lower 
hemoglobin (Hb; Supplementary figure 3B), mean cell volume (MCV; Supplementary 
figure 3C) and RBC number (Supplementary figure 3D).  All the mice fed an ID diet 
had significantly lower Hb, MCV and RBC number. These lower values were 
expected as the ID diet was expected to induce anemia in the mice. 
We assessed the morphology of the liver and spleen of the control and KO mice by 
performing H&E staining on the liver and spleen sections. Supplementary figure 1 B 
shows that although the spleens of both control and KO mice fed an ID diet show 
signs of EMH, only the livers of KO mice fed an ID diet had a significant 
accumulation of nucleated erythroid cells as shown by the black arrows in the bottom 
right panel of Supplementary figure 1B. These observations suggested that the KO 
mice had significantly increased EMH in the liver and spleen as compared to the 
control mice on an ID diet. 
We examined the EMH phenotype by qRT-PCR analysis of the genes involved in 
erythropoiesis on RNA isolated from the BM (Figure 2A), spleen (Figure 2B) and liver 
(Figure 2C) of control and KO animals. Relative levels of aminolevulinic acid 
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synthase 2 (Alas2), glycophorin A (Gypa), hydroxymethylbilane synthase (Hmbs), 
and transferrin receptor 1 (Tfr1) were measured.  
Although qRT-PCR analysis of the BM did not reveal any significant increases in the 
expression of the genes involved in erythropoiesis, there was a general increasing 
trend in the KO mice fed an ID diet (Figure 2A), except for Tfr1 which exhibited a 
downward trend. Figure 2B shows that the relative levels of Alas2, Gypa, Hmbs and 
Tfr1 were significantly increased in the spleens of the KO mice fed an ID diet as 
compared to mice fed a control diet. These results indicate increased erythropoietic 
activity in the spleen. Similarly, the levels of Alas2, Hmbs and Tfr1 were significantly 
increased in the livers of the KO mice fed an ID diet and Gypa showed an increasing 
trend. These results suggest increased EMH in the livers of the KO mice fed an ID 
diet (Figure 2C).   
 
Accumulation of immature erythroid cells in the bone marrow and spleen of KO mice 
fed an ID diet 
We further examined the EMH phenotype in the spleens and BM of KO mice on an 
ID diet by performing flow cytometric analysis on splenocytes and BM cells. The cells 
were stained with TER119, an erythroid marker, and CD44, another cell surface 
marker used for separating differentiating erythroblasts into their five stages of 
development [29]. An analysis of erythroid cells (TER119- positive cells) revealed 
that both the BM and spleen of the KO mice fed an ID diet had significantly 
increased numbers of immature erythroid cells (Bottom right panels in Figure 3A & 
3B), particularly in population III, which predominantly represents the polychromatic 
erythroblasts [29].  
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The percentage of erythroid cells that were polychromatic erythroblasts was 
significantly increased in the spleen and the BM of the KO mice fed an ID diet, 
suggesting that there was a developmental block in erythropoiesis in the KO mice as 
shown in Figure 3C and D. There was also a significant reduction in the percentage 
of mature erythroid cells in population V (predominantly RBCs and reticulocytes [29] 
in the BM and spleens of KO mice fed an ID diet (Figure 3C & 3D). These results are 
in agreement with previous studies that suggested a loss of TFR2 results in a delay 
in the differentiation of erythroblasts [20, 23]. 
We also examined the expression of Epor, Fam132b, Tfr1 and Tfr2 using RNA 
extracted from the four different populations of erythroid cells isolated from the BM 
(Figure 4A) and spleen (Figure 4B) of the control and KO mice fed an ID diet. 
Although we isolated all five populations of the erythroid cells, we could only use 
populations II-V for further analysis due to the quality of the RNA.  
The mRNA levels of Tfr1 and Epor were significantly higher in population 3 in the KO 
mice in both the BM and spleen. Fam132b expression levels were also increased in 
all the populations of the mice fed an ID diet, although this increase was not 
significant. These results indicate an increase in the erythropoietic drive in the KO 
mice fed an ID diet supporting the hypothesis that Tfr2 is required for a proper 
erythropoietic response in iron-deficiency anemia. 
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Discussion 
Previous studies have suggested that TFR2 is expressed in erythroid cells [14] and 
is regulated by erythroid-specific transcription factors in vivo [15]. GWAS have 
suggested a correlation between the TFR2 genomic region and various 
hematological traits [16-19]. Recent studies using mouse models of anemia have 
suggested that loss of Tfr2 in the erythroid compartment could be responsible for 
either increased RBC counts [21, 22, 24] or a block in the development of 
erythroblasts [23]. TFR2 was shown to be required for the proper localization and 
trafficking of EPOR to the surface in an erythroleukemic cell line [20]. These results 
taken together suggest that TFR2 has a role in erythropoiesis. 
We examined the role of TFR2 in erythroid cells by generating a hematopoietic-
specific knock-out model of TFR2 using Vav-Cre+/- mice on a C57BL/6J background. 
The mice used for this study were heterozygous for the floxed and knockout allele for 
TfR2, as previously suggested[26]. This was done to avoid the germ-line 
transmission of a Tfr2-deleted allele that has been previously reported to occur when 
using the Vav-Cre transgene [25].  
Even though there was a reduction in the levels of Tfr2 in the livers of the KO mice 
(Figure 1C), it did not affect the body iron status, as the iron indices (Figure 1D) were 
not significantly different between the two genotypes fed the same diet. These 
results indicated that the model did not have any abnormalities in systemic iron 
homeostasis and was suitable for examining the role of Tfr2 specifically in the 
erythroid compartment.  
It has been suggested that the erythropoietic function of TFR2 is evident only in iron-
restricted conditions such as anemia, where anemic mice lacking Tfr2 had altered 
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phenotypes [21-23]. In the previous studies anemia was achieved by disruption of 
the Tmprss6 gene, leading to enhanced hepcidin expression in the liver and hence a 
reduction in iron levels. In the present study, in order to establish anemic conditions, 
the mice were fed an ID diet for 10 weeks from birth. The hematological parameters 
in these mice indicated anemia, compared to the mice fed a control diet 
(Supplementary figure 3). Although the Hb, MCV and RBC numbers were lower in 
the KO mice fed an ID diet, there were no significant differences in the hematological 
parameters between the KO and the control mice fed an ID diet.  
One of the observations made while sacrificing the animals was that the spleens of 
the anemic mice were enlarged (splenomegaly) (Supplementary figure 3A). This was 
expected, as the drive to produce more erythrocytes in anemia, results in EMH. H&E 
staining of the spleen revealed signs of EMH but surprisingly there were islands of 
nucleated erythroid cells also present in the livers of the KO mice fed an ID diet. This 
observation was different from the recent study published by our laboratory where 
the Tmprss6-/-/Hfe-/-/Tfr2-/- and Tmprss6-/-/Tfr2-/- mice had splenomegaly and EMH in 
the spleen, but the liver sections of these animals appeared normal [23]. This could 
be due to differences in the two anemic models, where the previous model was 
anemic due to a genetic mutation and the model used in this study is based on 
dietary anemia.  
qRT-PCR analysis of the genes involved in erythropoiesis confirmed that there was 
increased expression of erythropoietic genes in the mice fed an ID diet and those 
expression levels were significantly higher in both the spleen and liver of the KO 
compared to control mice fed an ID diet (Figure 2B and C). The relative expression 
of erythropoietic genes was higher in the BM of the KO mice fed an ID diet but did 
not reach statistical significance (Figure 2A). Flow cytometric analysis of the 
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erythroid cells from the spleen and BM revealed that there was a significant increase 
in immature erythroid cells of a specific cell population (polychromatic erythroblasts) 
and a significant decrease in the mature cells in the anemic KO mice (Figure 3). 
Unlike the Tmprss6-/-/Hfe-/-/Tfr2-/- and Tmprss6-/-/Tfr2-/- mice, the anemic KO mice 
had increased polychromatic erythroblasts in both spleen and BM [23]. These results 
suggest that deletion of Tfr2 in the hematopoietic stem cells produces a novel model 
to study the role of Tfr2 in erythropoiesis [23]. An analysis of the four different 
erythroid progenitor cells also revealed increased Epor, Tfr1 and Fam132b mRNA 
expression in the cells of the KO mice as compared to the control mice. These 
results point to an essential role of erythroid Tfr2 in an efficient erythropoietic 
response to dietary anemia. 
Previous studies had suggested a role for Tfr2 in erythropoiesis based on the 
assumption that the absence of Tfr2 in the erythroid compartment was responsible 
for the phenotype observed but the models used in those studies lacked Tfr2 in all 
other tissues as well [22 , 23]. In this study the deletion is shown to be in the BM 
cells and the phenotype can be attributed to the lack of TFR2 specifically in the 
hematopoietic cells, as it has not been previously reported that mice lacking Tfr2 in 
the hepatocytes have abnormalities in hematological parameters or splenomegaly 
[13, 22]. Results published by our laboratory using a different model of anemia 
where the anemic mice lacking Tfr2 had splenomegaly and EMH, have also 
suggested a role for Tfr2 in iron-restricted erythropoiesis [23]. There are a few 
differences in the two models; firstly the anemia in the KO mice used for this study 
was dietary anemia, in contrast to the iron refractory iron deficiency anemia in the 
Tmprss6-/- mice. Secondly, the Tmprss6-/- also developed alopecia (loss of hair) 
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whereas the KO mice fed an ID diet did not. The KO mice in this study did not have 
high Hamp levels, in contrast to the Tmprss6-/-/Tfr2-/- mice which did[23].  
The results of our study are also different from Nai et al [24]. We observed a 
decrease in RBC number, whereas in their model, Nai et al observed an increase. 
The anemic mice in their study did not develop splenomegaly, indicating that the 
degree of anemia was mild. The differences in the two studies may be explained on 
the basis of the mouse models used. Nai et al injected WT mice with BM transplants 
from Tfr2 KO mice. It has been shown that Tfr2 KO mice have significant iron 
overload which predisposes their BM cells to higher levels of iron as well. This may 
have resulted in the activation of alternate iron-dependent pathways in those mice. 
Secondly, the mice were fed an ID diet for only 3 weeks after the transplant; this 
resulted in a very mild anemia as acknowledged by the authors [24]. In contrast, the 
mice used in our study were fed an ID diet from birth leading to severe anemia and 
the induction of iron-deficiency related erythropoiesis.  
Our studies provide definitive evidence for a novel role for erythroid TFR2 expression 
in erythropoiesis. It will be important to examine whether Tfr2 has a role in other 
models of anemia such as β-thalassemia or the anemia of chronic disease and 
whether the absence of Tfr2 in the hematopoietic compartment affects the severity of 
disease in these models. Our findings may also be relevant to clinical scenarios such 
as chronic anemia or diseases where an immediate and effective erythropoietic 
response is required. In the absence of Tfr2 there would be a delay in the production 
of mature RBCs leading to other complications.  
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Figure legends 
Figure 1. Loss of Tfr2 in the hematopoietic compartment does not affect 
systemic iron homeostasis. mRNA expression levels of Tfr2 (relative to the 
geometric mean of three reference genes: β-actin, Hprt and Polr2a) were measured 
in the (A) bone marrow, (B) spleen and (C) liver of 10-week-old control (●) and KO 
(■) male mice (n = 4-5 per group) fed a control or iron-deficient diet (ID). (D) Hepatic 
iron concentration (HIC), splenic iron concentration (SIC), total serum iron and  
transferrin saturation were measured in the spleen and liver of 10-week-old control 
(●Tfr2∆/f) and KO (■Tfr2∆/f/Vav-Cre+/-) male mice (n = 4-5 per group) fed a control or 
ID diet. Data are shown as dot plots with the mean and standard error of the mean 
(SEM). Statistically significant differences (two-way ANOVA using Tukey’s multiple 
comparison test; p<0.05) are denoted as (a) compared to the respective genotype 
and (b) compared to the respective control treatment group. 
Figure 2. Increased extramedullary hematopoiesis in the spleen and liver of KO 
mice fed an ID diet. mRNA expression levels of Alas2, Gypa, Hmbs and Tfr1 
(relative to the geometric mean of three reference genes: β-actin, Hprt and Polr2a) 
were measured in the (A) BM, (B) spleens and (C) livers of 10-week-old control (●) 
and KO (■) male mice (n = 4-5 per group) fed a control or ID diet. Data are shown as 
dot plots with the mean and standard error of the mean (SEM). Statistically 
significant differences (two-way ANOVA using Tukey’s multiple comparison test; 
p<0.05) are denoted as (b) compared to the respective control treatment group. 
 
Figure 3. Accumulation of polychromatic erythroblasts in the bone marrow and 
spleen of KO mice fed an ID diet. (A) BM cells and (B) splenocytes from 10-week-
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old control and KO male mice (n = 4-5 per group) fed a control or ID diet were 
stained with TER119-fluorescein, CD44-allophycocyanin and CD44 vs. forward 
scatter (FSC-A) was plotted for all TER119 positive cells resulting in five distinct 
populations as described in Chen et al [29] and shown in the top left panel. The 
percentage of erythroid cells (TER119+) belonging to each population of the 
erythroblasts (I, II, III, IV and V) was calculated in the (C) BM cells and (D) 
splenocytes of 10-week-old control (C) and KO male mice (n = 4-5 per group) fed a 
control or ID diet. Data are shown as stacked bar graphs with the mean. Statistically 
significant differences (two-way ANOVA using Tukey’s multiple comparison test are 
denoted * (p<0.05) and *** (p<0.001) compared to the corresponding genotype on 
the same diet. 
 
Figure 4. Gene expression in isolated erythroblasts. mRNA expression levels of 
Epor, Fam132b, Tfr1 and Tfr2 (relative to the geometric mean of three reference 
genes: β-actin, Hprt and Polr2a) were measured in the erythroid cells isolated from 
(A) BM cells and (B) splenocytes of 10-week-old control (●) and KO (■) male mice (n 
= 3 per group) fed an ID diet. Data are shown as stacked bar graphs with the mean. 
Statistically significant differences (two-way ANOVA using Tukey’s multiple 
comparison test are denoted * (p<0.05) and ** (p=0.001) compared to the control 
genotype. 
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